This week's scan flagged a clear pattern: price is moving faster than consensus across a small but notable cluster of names. Using the FMP Price Target Summary Bulk API, five stocks surfaced where the spread between current trading levels and analyst targets has widened enough to suggest a lag in model updates rather than a shift in fundamentals.
This note breaks down that signal — how the gap is forming, where it's most pronounced, and how the same API-driven workflow can be used to track these dislocations systematically.
This Week's Screen: Where Price Is Getting Ahead of Consensus
MercadoLibre, Inc. (MELI)
Current Price: $1,773.96 • Consensus Target: $2,775 • Upside Potential: ~56.4%
MercadoLibre stands out here because the gap is large, but the underlying story is not one of obvious operating weakness. The company reported revenue above expectations in late February even as quarterly profit declined 12.5%, with the earnings miss attributed in part to credit-related pressure. That matters for interpreting the screen: the spread between price and target does not read like a simple “market is missing growth” setup. It looks more like a case where the equity has been digesting a more complicated mix of strong top-line momentum and tighter scrutiny around profitability quality, especially inside the fintech and credit stack.
There is also a broader allocation context around the name. MercadoLibre plans to invest 57 billion reais, about $10.9 billion, in Brazil this year, up 50% from 2025. That kind of step-up reinforces the scale of its regional ambition, but it also gives the market another reason to focus on execution, capital intensity, and return discipline rather than on revenue growth alone. In a target-gap framework, that is often where consensus lags: not because analysts lack conviction in the business, but because the timing of margin interpretation and investment digestion shifts faster in the market than in published models. The datasets that best illuminate this story are the income statement, segment-level operating metrics, and analyst target revisions, especially where credit costs and commerce margins are moving at different speeds.
Carvana Co. (CVNA)
Current Price: $336.31 • Consensus Target: $465.33 • Upside Potential: ~38.4%
Carvana's screen result is notable because it comes after a period in which the equity had already repriced dramatically higher before encountering a more complicated operating readout. Carvana missed Wall Street expectations for fourth-quarter profit, with higher vehicle reconditioning costs and depreciation weighing on results. But the stock had more than doubled in 2025. That sequence matters. When a stock has already undergone a large narrative re-rating, the market often becomes far less tolerant of cost slippage, even when the broader demand backdrop remains constructive.
The persistence of a large consensus gap suggests analysts still see the company through the lens of scale recovery, demand normalization, and operating leverage, while the market is focusing more closely on unit economics. That does not invalidate the higher targets; it simply shows that price is reacting faster to margin sensitivity than the consensus framework is updating. For a name like Carvana, this kind of divergence often says more about confidence intervals than about direction. The right data to watch are retail unit growth, GPU and EBITDA per unit, inventory turn and reconditioning costs, and analyst estimate revisions after quarterly prints. Those datasets do a better job of explaining the signal than a headline target alone.
Expand Energy Corporation (EXE)
Current Price: $98.99 • Consensus Target: $136.7 • Upside Potential: ~38.1%
For Expand Energy, the signal is less about company-specific disruption and more about how quickly gas-linked equities are being repriced against a changing commodity backdrop. Global LNG supply is expected to rise materially in 2026, a shift that analysts expect to ease the tightness that defined earlier years. That combination is important: the macro gas narrative is no longer a simple scarcity trade. It is becoming a more nuanced discussion about demand durability, export optionality, and the shape of pricing as new supply enters the system.
That is why a wide price-to-target spread in EXE deserves careful reading. When consensus targets remain meaningfully above spot, it can reflect the fact that sell-side models are anchored to longer-cycle commodity assumptions or to the strategic value of low-cost gas inventory, while the stock is reacting more immediately to front-end pricing, basis risk, and sentiment around the LNG curve. The gap here is notable, but the useful question is not whether price is “wrong.” It is whether the market is discounting a more volatile near-term gas tape than analysts are currently embedding. To illustrate that properly, the most relevant datasets would be realized pricing and production volumes, hedging disclosures, reserve and cost data, and analyst target histories tied to natural-gas benchmark changes.
Summit Therapeutics Inc. (SMMT)
Current Price: $19.67 • Consensus Target: $26 • Upside Potential: ~32.2%
Summit is a different kind of target-gap name because the divergence is being driven by clinical and regulatory interpretation rather than by a conventional earnings model. In its February 2026 filing, the company said the FDA accepted for filing the BLA for ivonescimab in combination with chemotherapy, with a PDUFA goal action date of November 14, 2026. Separately, Summit disclosed in January a clinical trial collaboration with GSK to evaluate ivonescimab in combination with GSK's antibody-drug conjugate across multiple solid tumor settings. Those are meaningful developments because they move the discussion from broad platform enthusiasm toward a more concrete regulatory timeline and development path.
In that context, the price-to-target gap should be read as a measure of how difficult it is for consensus to keep pace with binary biotechnology risk once the narrative shifts from promise to milestones. Analyst targets in biotech often express probability-weighted views over a longer arc, while the stock itself can compress or expand quickly around filing status, combination strategy, and the market's reading of competitive positioning in immuno-oncology. Here, the signal is less about valuation in the abstract and more about timing mismatch: published targets may still reflect the broader ivonescimab franchise opportunity, while the stock is processing nearer-term uncertainty one catalyst at a time. The most informative datasets for this story are regulatory filings, clinical-trial pipeline disclosures, cash runway and liquidity, and analyst target changes following major trial or FDA events.
Evercore Inc. (EVR)
Current Price: $337.90 • Consensus Target: $399.33 • Upside Potential: ~18.2%
Evercore's spread is smaller than the others, but it is arguably one of the more interesting ones because advisory names sit at the intersection of sentiment, capital markets activity, and forward expectations for deal flow. Large U.S. banks are expected to show stronger investment-banking fees, helped by elevated deal activity in the first quarter, even as the macro outlook remains less settled because of geopolitical risk and rate uncertainty. Moreover, global investment-banking revenues exceeded $100 billion in 2025, reinforcing the idea that the recovery in dealmaking had already become visible before 2026 began.
That backdrop helps explain the signal. Advisory firms like Evercore are often priced on the durability of pipelines rather than on current-quarter earnings alone, so a discount between price and target can emerge when investors accept that activity has improved but remain unconvinced about how linear the recovery will be. In other words, the market may be applying a higher discount rate to advisory revenues than consensus targets currently imply. That is not a contradiction; it is exactly the kind of timing mismatch a target-gap screen is designed to catch. The most useful datasets here would be advisory fee revenue, league-table position, compensation ratio trends, and M&A pipeline indicators, because those measures reveal whether the stock is trading more on present execution or on the confidence attached to future deal conversion.
Interpreting the Gap: What the Divergence Is Signaling
Taken together, the five names in this week's screen point to a consistent dynamic: the market is compressing timelines faster than consensus models are updating assumptions. The gap cuts across sectors — e-commerce, energy, biotech, autos, and advisory — suggesting this is less about isolated mispricing and more about how quickly price absorbs incremental information relative to model refresh cycles.
The divergence itself is rarely driven by a single factor. In MercadoLibre and Carvana, it reflects tension between strong revenue narratives and shifting margin interpretation. In Expand Energy, it maps to how the market is recalibrating forward commodity assumptions. Summit's spread is tied to milestone-driven uncertainty, while Evercore captures how sentiment around deal flow can reprice faster than advisory estimates adjust. The common thread is not disagreement on direction, but a lag in how different inputs are incorporated.
A simple price-target comparison only captures the surface. The signal becomes more useful when layered: aligning analyst targets with income statement data helps show whether earnings revisions are catching up to price, while cash flow and balance sheet data clarify whether capital intensity or liquidity dynamics are driving the move. In practice, this kind of multi-layered view is only possible when the underlying datasets are standardized — something platforms like Financial Modeling Prep enable by keeping inputs consistent across endpoints.
There is also a behavioral element embedded in the gap. When targets remain elevated despite volatility, it can reflect either conviction in long-term assumptions or a delay in estimate revisions. Bringing in analyst estimate histories alongside ownership or insider activity adds context, helping distinguish between structural belief and gradual repositioning.
Seen through that lens, price-consensus divergence is less a valuation anomaly and more a timing signal — a way to identify where the market narrative is evolving faster than the frameworks used to model it.
Constructing a Systematic Target-Gap Workflow with FMP
A price-target spread only becomes useful when the calculation can be reproduced reliably. That means fixing the data inputs, pulling them in a consistent sequence, and applying the same formula every time the screen runs. Once those elements are standardized, the exercise stops being a one-off comparison and turns into a process that can be refreshed on a schedule.
The only requirement before running the workflow is a valid API key.
Step 1: Pull Analyst Price Targets
The process starts by establishing where consensus currently sits. This is done by querying the Price Target Summary Bulk API, which returns average price targets along with analyst participation counts across the ticker set in a single call. That combination matters: the average target provides the reference level, while coverage depth helps contextualize how representative that number is. Together, they form the baseline against which market prices will be compared.
Endpoint:
https://financialmodelingprep.com/stable/price-target-summary-bulk?apikey=YOUR_API_KEY
Sample Response:
[
{
"symbol": "AAPL",
"lastQuarterCount": "12",
"lastQuarterAvgPriceTarget": "228.15",
"lastYearAvgPriceTarget": "205.34"
}
]
Step 2: Pull Latest Market Prices
Once targets are in place, the next input is the current trading price. This comes from the Company Profile Data API, which includes the most recent quote used for comparison. At this stage, the goal isn't granularity or intraday precision — it's simply to anchor each name to the same market reference point so gaps are calculated consistently.
https://financialmodelingprep.com/stable/profile/AAPL?apikey=YOUR_API_KEY
Step 3: Derive the Target Gap
Once both values are available, the gap itself is straightforward to compute. Express it as a percentage to normalize results across different price levels:
Upside % = (Price Target - Current Price) / Current Price × 100
Using percentages allows large-cap and lower-priced names to sit in the same ranking without distortion.
Step 4: Apply a Threshold Filter
The final layer is judgment. Most workflows introduce a minimum threshold — often around 20% — to filter out routine variance and focus attention on gaps that are large enough to matter. At this stage, analyst coverage becomes part of the interpretation: a wide gap backed by broad, recent coverage carries a different weight than one driven by a small or outdated estimate set.
Structured this way, the process moves beyond a simple valuation screen. It becomes a repeatable diagnostic tool — one that highlights where price and consensus are drifting apart and does so in a way that can be refreshed, audited, and scaled across time and coverage universes.
Scaling a Desk Signal Into Institutional Workflow
Most quantitative workflows begin quietly — a model or screen built by a single analyst to answer a recurring question with greater consistency. The first version usually lives in a spreadsheet or a small script: efficient, practical, and tailored to the needs of one desk. The turning point arrives when the signal proves useful enough that colleagues begin asking for it. Replication follows, and with it comes an unintended side effect: slight variations in endpoints, refresh schedules, or calculation logic start producing subtly different results.
At that stage, the analyst who created the workflow often becomes an informal architect of standardization. The challenge shifts from running the screen to defining the method behind it. Institutional value emerges when the process is formalized: the data sources are fixed, the sequence of API pulls is documented, formulas are locked, and thresholds are explicitly defined. Once those elements are stabilized, the workflow stops being a personal tool and begins to function as a shared research input.
Moving the process into a centralized dashboard with scheduled updates is usually the next step in that evolution. Instead of circulating spreadsheets or ad-hoc scripts, teams interact with the same data pipeline and the same calculation framework. This reduces workflow fragmentation across research groups and allows portfolio managers, analysts, and risk teams to reference the same signal simultaneously. When everyone is drawing from the same dataset and methodology, discussions shift away from reconciling numbers and toward interpreting what the signal actually means.
Standardization also strengthens governance and transparency. A centralized workflow creates a visible audit trail: where the data originated, when it refreshed, and how each metric was derived. That lineage matters in institutional environments where reproducibility is essential. When colleagues run the same query and obtain the same result, the signal becomes dependable infrastructure rather than a one-off analytical shortcut.
Scaling that kind of workflow across a team requires stable access to the underlying datasets and consistent distribution across users. Infrastructure becomes less about adding features and more about removing friction from the research process. Platforms designed for institutional usage — such as FMP's Enterprise plan — provide the access controls, refresh stability, and shared environment needed when a desk-level workflow transitions into a broader research tool.
When that transition happens successfully, the model itself changes role. The target-gap screen is no longer simply a clever comparison between price and analyst targets. It becomes part of the firm's analytical framework — a standardized diagnostic that multiple teams can rely on to identify where market pricing and consensus expectations are beginning to drift apart.
When the Market Reprices Before the Story Catches Up
When price moves ahead of consensus, the signal isn't in the gap itself — it's in how quickly the narrative is being repriced relative to the models meant to explain it. The same workflow built on the FMP Price Target Summary Bulk API offers a consistent way to track that shift as it unfolds, rather than after revisions catch up.
If you enjoyed this analysis, you'll also want to read: Weekly Signals Desk | Four Dividend Increases Flagged by the FMP API (March 30 - April 3)
Disclosure: Signals Desk content is provided for informational and analytical purposes only and does not constitute investment advice or trade recommendations. The analysis reflects interpretation of market data and publicly disclosed or third-party information, including data accessed via Financial Modeling Prep APIs, at the time of publication. Signals discussed are probabilistic, can be wrong, and may change as market conditions and consensus data evolve. This content should be considered alongside broader research, individual objectives, and risk assessment.
